logo
Sign in

CYTK Stock Price, Chart, Stats & News

Cytokinetics, Incorporated
Save
9.80B
Market cap
Current P/E
117.65x
Forward P/E

CYTK chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
-22.29%
Operating margin
-695.44%
Pretax margin
-891.60%
Net margin
-891.60%
Effective tax rate
ROA
-55.10%
ROE
172.91%
D/E
-1.95x
Interest coverage ratio
-5.89x

CYTK valuation

P/E
P/S
87.43x
P/B
-11.56x
P/CF
-14.95x
P/FCF
-14.39x
P/OCF
-14.95x
PEG
2.78x
EV multiple
-10.40x

About

Cytokinetics, Incorporated is an advanced biopharmaceutical company dedicated to the research, development, and commercialization of therapies that modulate muscle function. These novel compounds aim to address debilitating diseases. The core of their pipeline consists of small molecule drug candidates specifically designed to influence muscle performance and contraction at a fundamental level.

Similar securities

Based on sector and market capitalization

Report issue